Access to treatment is a key challenge in the elimination of hepatitis B.

A new study in Hepatology International examines the pricing and affordability of HBV treatment across the Asia–Pacific region, highlighting financial barriers that impact patient care and public health goals.

Read the full article here:

https://link.springer.com/article/10.1007/s12072-024-10744-9